Chemical Compound

Microcystin YR

CAS Registry Number 101064-48-6
Microcystin YR chemical structure
Primary Record

Microcystin YR

Note: Only for scientific research or as raw materials for production.

In stock
8,529 g
Purity
98.6 %
CAS
101064-48-6

Compound Identifiers & Properties

CAS
101064-48-6
PubChem CID
6437088
SMILES
C[C@H]1[C@@H](NC(=O)[C@@H](NC(=O)[C@H]([C@@H](NC(=O)[C@@H](NC(=O)[C@H](NC(=O)C(=C)N(C(=O)CC[C@@H](NC1=O)C(=O)O)C)C)CC2=CC=C(C=C2)O)C(=O)O)C)CCCN=C(N)N)/C=C/C(=C/[C@H](C)[C@H](CC3=CC=CC=C3)OC)/C
Canonical SMILES
C=C1C(=O)N[C@H](C)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](C(=O)O)[C@H](C)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](/C=C/C(C)=C/[C@H](C)[C@H](Cc2ccccc2)OC)[C@H](C)C(=O)N[C@@H](C(=O)O)CCC(=O)N1C

Names & Synonyms

  • Microcystin YR
  • Microcystin-YR
  • Cyanoginosin YR
  • Cyanoginosin-YR
  • Microcystin LR
  • MCYR
  • MC-YR
  • AC1O5MZH
  • RefChem:818841
  • 101064-48-6
  • CHEMBL4633668
  • UNII-4G08121T5U
  • DTXSID00880086
  • Cyanoginosin LA, 3-tyrosyl-5-arginine-
  • orb2813714
  • cyanoginosin LA, 3-L-tyrosyl-5-L-arginine
  • 4G08121T5U
  • SCHEMBL29349519
  • OWHASZQTEFAUJC-GJRPNUFSSA-N
  • DTXCID101526874
  • BDBM50542676
  • C52H72N10O13
  • MSK001280
  • MSK001280-10M
  • CID6437088
  • FM73137
  • C19997
  • C52-H72-N10-O13
  • Cyanoginosin LA, 3-L-tyrosine-5-L-arginine
  • Microcystin YR from Microcystis aeruginosa
  • LS-182803
  • Microcystin YR Solution in Methanol, 10ug/mL
  • Microcystin-YR, ca. 11ug/ml in 50% acetonitrile
  • 18-hydroxy-17-noraphidicolan-16-one ethylene acetal
  • CYANOGINOSIN LA, 3-L-TYROSINE-5-L-ARGININE-
  • Q27259546
  • (5R,8S,11R,12S,15S,18S,19S,22R)-15-[3-(diaminomethylideneamino)propyl]-8-[(4-hydroxyphenyl)methyl]-18-[(1E,3E,5S,6S)-6-methoxy-3,5-dimethyl-7-phenylhepta-1,3-dienyl]-1,5,12,19-tetramethyl-2-methylidene-3,6,9,13,16,20,25-heptaoxo-1,4,7,10,14,17,21-heptazacyclopentacosane-11,22-dicarboxylic acid
  • (5R,8S,11R,12S,15S,18S,19S,22R)-15-(3-(diaminomethylideneamino)propyl)-8-((4-hydroxyphenyl)methyl)-18-((1E,3E,5S,6S)-6-methoxy-3,5-dimethyl-7-phenylhepta-1,3-dienyl)-1,5,12,19-tetramethyl-2-methylidene-3,6,9,13,16,20,25-heptaoxo-1,4,7,10,14,17,21-heptazacyclopentacosane-11,22-dicarboxylic acid
  • (5R,8S,11R,12S,15S,18S,19S,22R)-15-(3-Carbamimidamidopropyl)-8-[(4-hydroxyphenyl)methyl]-18-[(1E,3E,5S,6S)-6-methoxy-3,5-dimethyl-7-phenylhepta-1,3-dien-1-yl]-1,5,12,19-tetramethyl-2-methylidene-3,6,9,13,16,20,25-heptaoxo-1,4,7,10,14,17,21-heptaazacyclopentacosane-11,22-dicarboxylic acid
  • (5R,8S,11R,12S,15S,18S,19S,22R)-15-[3-(Carbamimidoylamino)propyl]-8-[(4-hydroxyphenyl)methyl]-18-[(1E,3E,5S,6S)-6-methoxy-3,5-dimethyl-7-phenylhepta-1,3-dien-1-yl]-1,5,12,19-tetramethyl-2-methylidene-3,6,9,13,16,20,25-heptaoxo-1,4,7,10,14,17,21-heptaazacyclopentacosane-11,22-dicarboxylic acid
  • 101064-52-2
  • 15-(3-((diaminomethylidene)amino)propyl)-8-((4-hydroxyphenyl)methyl)-18-(6-methoxy-3,5-dimethyl-7-phenylhepta-1,3-dien-1-yl)-1,5,12,19-tetramethyl-2-methylidene-3,6,9,13,16,20,25-heptaoxo-1,4,7,10,14,17,21-heptaazacyclopentacosane-11,22-dicarboxylic acid
  • 621-458-3
  • CYCLO(2,3-DIDEHYDRO-N-METHYLALANYL-D-ALANYL-L-TYROSYL-(3S)-3-METHYL-D-.BETA.-ASPARTYL-L-ARGINYL-(2S,3S,4E,6E,8S,9S)-3-AMINO-9-METHOXY-2,6,8-TRIMETHYL-10-PHENYL-4,6-DECADIENOYL-D-.GAMMA.-GLUTAMYL)
  • CYCLO(2,3-DIDEHYDRO-N-METHYLALANYL-D-ALANYL-L-TYROSYL-ERYTHRO-3-METHYL-D-.BETA.-ASPARTYL-L-ARGINYL-(2S,3S,4E,6E,8S,9S)-4,5,6,7-TETRADEHYDRO-9-METHOXY-2,6,8-TRIMETHYL-10-PHENYL-3-AMINODECANOYL-D-.GAMMA.-GLUTAMYL)
  • Cyclo[2,3-didehydro-N-methylalanyl-D-alanyl-L-tyrosyl-(3S)-3-methyl-D-.beta.-aspartyl-L-arginyl-(2S,3S,4E,6E,8S,9S)-3-amino-9-methoxy-2,6,8-trimethyl-10-phenyl-4,6-decadienoyl-D-.gamma.-glutamyl]
  • N-METHYLCYCLO(DHA-D-ALA-L-TYR-((3S)-3-METHYL-D-BETAASP-)-L-ARG-((2S,3S)-2-METHYL-3-((1E,3E,5S,6S)-3,5-DIMETHYL-6-METHOXY-7-PHENYLHEPTA-1,3-DIENE-1-YL)-BETAALA-)-D-GAMMAGLU-)